miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy

Oncology Reports

Volumn 34, Issue 1, 2015, Pages 368-374

  Yin, Wenjun ^a   Nie, Yuehua ^a   Zhang, Zhiwei ^a   Xie, Liming ^a   He, Xiusheng ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Apoptosis; Caspase 3; Cisplatin; Hepatocellular carcinoma; Mcl 1; miR 193b

Indexed keywords

CASPASE 3; CISPLATIN; MICRORNA; MICRORNA 193B; PROTEIN BCL 2; PROTEIN MCL 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ANTINEOPLASTIC AGENT; CASP3 PROTEIN, HUMAN; MCL1 PROTEIN, HUMAN; MIRN193 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER TISSUE; CELL DEATH; CHEMOSENSITIZATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HEPG2 CELL LINE; HUMAN; HUMAN TISSUE; MCL 1 GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DOWN-REGULATION; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICRORNAS; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; SIGNAL TRANSDUCTION;

EID: 84930012488     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3996     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Nault JC, Calderaro J, Di Tommaso L, Balabaud C, Zafrani ES, Bioulac-Sage P, Roncalli M and Zucman-Rossi J: Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. Hepatology 60: 1983-1992, 2014.
3. Kerr SH and Kerr DJ: Novel treatments for hepatocellular cancer. Cancer Lett 286: 114-120, 2009.
4. Arslan C, Ozdemir E, Dogan E, Ozisik Y and Altundag K: Secondary hematological malignancies after treatment of non-metastatic breast cancer. J BUON 16: 744-750, 2011.
5. Roufayel R, Johnston DS and Mosser DD: The elimination of miR-23a in heat-stressed cells promotes NOXA-induced cell death and is prevented by HSP70. Cell Death Dis 27: e1546, 2014.
6. Nair N and Gongora E: MicroRNAs as therapeutic targets in cardiomyopathies: Myth or reality? Biomol Concepts 5: 439-448, 2014.
7. Zhang H, Cheng Y, Jia C, Yu S, Xiao Y and Chen J: MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability. Med Oncol 32: 342, 2015.
8. Zhang L, Ge Y and Fuchs E: miR-125b can enhance skin tumor initiation and promote malignant progression by repressing differentiation and prolonging cell survival. Genes Dev 28: 2532-2546, 2014.
9. Wang S and Li K: MicroRNA-96 regulates RGC-5 cell growth through caspase-dependent apoptosis. Int J Clin Exp Med 7: 3694-3702, 2014.
10. Wolfson B, Eades G and Zhou Q: Roles of microRNA-140 in stem cell-associated early stage breast cancer. World J Stem Cells 6: 591-597, 2014.
11. Mo ZH, Wu XD, Li S, Fei BY and Zhang B: Expression and clinical significance of microRNA-376a in colorectal cancer. Asian Pac J Cancer Prev 15: 9523-9527, 2014.
12. Woo SM, Min KJ, Seo BR, Nam JO, Choi KS, Yoo YH and Kwon TK: Cafestol overcomes ABT-737 resistance in Mcl-1-overexpressed renal carcinoma Caki cells through downregulation of Mcl-1 expression and upregulation of Bim expression. Cell Death Dis 5: e1514, 2014.
13. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179, 2005.
14. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
15. Amaral C, Borges M, Melo S, da Silva ET, Correia-da-Silva G and Teixeira N: Apoptosis and autophagy in breast cancer cells following exemestane treatment. PLoS One 7: e42398, 2012.
16. Mu YP, Tang S, Sun WJ, Gao WM, Wang M and Su XL: Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer. Asian Pac J Cancer Prev 15: 8893-8900, 2014.
17. Li J, Kong F, Wu K, Song K, He J and Sun W: miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer. Mol Med Rep 10: 2613-2620, 2014.
18. Liu R, Liu X, Zheng Y, Gu J, Xiong S, Jiang P, Jiang X, Huang E, Yang Y, Ge D, et al: MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel. Oncol Lett 8: 2193-2200, 2014.
19. Boyerinas B, Park SM, Murmann AE, Gwin K, Montag AG, Zillhardt M, Hua YJ, Lengyel E and Peter ME: Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1. Int J Cancer 130: 1787-1797, 2012.
20. Koga C, Kobayashi S, Nagano H, Tomimaru Y, Hama N, Wada H, Kawamoto K, Eguchi H, Konno M, Ishii H, et al: Reprogramming using microRNA-302 improves drug sensitivity in hepatocellular carcinoma cells. Ann Surg Oncol 21 (Suppl 4): S591-S600, 2014.
21. Creagh EM: Caspase crosstalk: integration of apoptotic and innate immune signalling pathways. Trends Immunol 35: 631-640, 2014.
22. Childs BG, Baker DJ, Kirkland JL, Campisi J and van Deursen JM: Senescence and apoptosis: Dueling or complementary cell fates? EMBO Rep 15: 1139-1153, 2014.
23. Setia S, Nehru B and Sanyal SN: Celecoxib prevents colitis associated colon carcinogenesis: An upregulation of apoptosis. Pharmacol Rep 66: 1083-1091, 2014.
24. Yang P, Tuo L, Wu Q and Cao X: Licochalcone-A sensitizes human esophageal carcinoma cells to TRAIL-mediated apoptosis by proteasomal degradation of XIAP. Hepatogastroenterology 61: 1229-1234, 2014.
25. Lee HG, Lee JM, Shin SJ, Kwon SH, Lee GS, Song CH, Choi ES, Cha SD and Cho CH: Salinomycin inhibited cell proliferation and induced apoptosis in human uterine leiomyoma cells. Obstet Gynecol Sci 57: 501-506, 2014.
26. Zhao J, Li X, Zou M, He J, Han Y, Wu D, Yang H and Wu J: miR-135a inhibition protects A549 cells from LPS-induced apoptosis by targeting Bcl-2. Biochem Biophys Res Commun 452: 951-957, 2014.
27. Rao YM, Shi HR, Ji M and Chen CH: miR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells. J Huazhong Univ Sci Technolog Med Sci 33: 567-572, 2013.
28. Zhang R, Li Y, Dong X, Peng L and Nie X: miR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer. Med Oncol 31: 347, 2014.
29. Geserick P, Wang J, Feoktistova M and Leverkus M: The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin. Cell Death Dis 5: e1412, 2014.